Volta Finance Analyst Q&A: Robust cash reflecting the asset selection by AXA (LON:VTA) 2 October 2020
Cambridge Cognition Holdings Q&A: Improved operating profit and cash position (LON:COG) 30 September 2020
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Watkin Jones Plc All 2017 deliveries now forward sold confidence in FY18 forecasts increasing – Zeus Capital 6 February 2017
Epwin Group PLC FY16 in line with expectations, delivering c.19% earnings growth – Zeus Capital 1 February 2017
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Real Estate with a 13% Potential Upside 23 January 2026
Worldwide Healthcare Trust (WWH.L): Exploring the Resilience and Strategy Behind Its Market Position 23 January 2026
Zigup Plc (ZIG.L) Stock Analysis: Potential Upside of Over 30% Amid Strong Dividends and Analyst Optimism 23 January 2026
Wetherspoon (JDW.L) Investor Outlook: Navigating Growth in the UK Restaurant Industry 23 January 2026
Volta Finance Analyst Q&A: Robust cash reflecting the asset selection by AXA (LON:VTA) 2 October 2020
Cambridge Cognition Holdings Q&A: Improved operating profit and cash position (LON:COG) 30 September 2020
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Watkin Jones Plc All 2017 deliveries now forward sold confidence in FY18 forecasts increasing – Zeus Capital 6 February 2017
Epwin Group PLC FY16 in line with expectations, delivering c.19% earnings growth – Zeus Capital 1 February 2017
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Real Estate with a 13% Potential Upside 23 January 2026
Worldwide Healthcare Trust (WWH.L): Exploring the Resilience and Strategy Behind Its Market Position 23 January 2026
Zigup Plc (ZIG.L) Stock Analysis: Potential Upside of Over 30% Amid Strong Dividends and Analyst Optimism 23 January 2026
Wetherspoon (JDW.L) Investor Outlook: Navigating Growth in the UK Restaurant Industry 23 January 2026
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotechnology Powerhouse with 19.66% ROE 8 December 2025
Regencell Bioscience Holdings (RGC): Unpacking the Dynamics of a $8 Billion TCM Innovator 8 December 2025
Telix Pharmaceuticals Limited (TLX): Investor Outlook with a Promising 115.84% Upside Potential 8 December 2025
Guardant Health, Inc. (GH) Investor Outlook: Analyzing a 38.5% Revenue Growth in the Precision Oncology Space 8 December 2025
Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Analyzing a 20% Potential Upside in the CNS Biotech Sector 8 December 2025
Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Volatility in the Biotech Sector 8 December 2025
Universal Health Services, Inc. (UHS): Stock Analysis Reveals Potential Upside and Strong Buy Ratings 8 December 2025
Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with a 26% Upside Potential 8 December 2025
Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Powerhouse With 362% Revenue Growth 8 December 2025
Masimo Corporation (MASI) Stock Analysis: Healthcare Innovator with a 29.69% Potential Upside 8 December 2025
BridgeBio Pharma, Inc. (BBIO): Growth Potential with a 14.95% Upside Amidst Biotech Innovations 8 December 2025
Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unlocking Growth Potential with Innovative Treatments 8 December 2025
Cooper Companies, Inc. (COO) Stock Analysis: 9.80% Potential Upside in Healthcare Innovator 8 December 2025
Bruker Corporation (BRKR) Stock Analysis: Navigating Growth with a 1.67% Potential Upside 8 December 2025
Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare’s Dynamic Landscape with Modest Upside 8 December 2025
Rhythm Pharmaceuticals (RYTM) Stock Analysis: Exploring a 21% Upside Potential in the Biotech Sector 8 December 2025
Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating Growth Amidst Challenges 8 December 2025
BlackRock Latin American Investment Trust – Opportunities Investing in Latin America (Interview) 20 October 2020
AstraZeneca’s Imfinzi shows positive results in Phase III trial for small cell lung cancer 5 April 2024
Safestore appoints accomplished finance leader Simon Clinton as Chief Financial Officer 22 February 2024
Volta Finance Analyst Q&A: Robust cash reflecting the asset selection by AXA (LON:VTA) 2 October 2020
Cambridge Cognition Holdings Q&A: Improved operating profit and cash position (LON:COG) 30 September 2020
Watkin Jones Plc All 2017 deliveries now forward sold confidence in FY18 forecasts increasing – Zeus Capital 6 February 2017
Epwin Group PLC FY16 in line with expectations, delivering c.19% earnings growth – Zeus Capital 1 February 2017
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Real Estate with a 13% Potential Upside 23 January 2026
Worldwide Healthcare Trust (WWH.L): Exploring the Resilience and Strategy Behind Its Market Position 23 January 2026
Zigup Plc (ZIG.L) Stock Analysis: Potential Upside of Over 30% Amid Strong Dividends and Analyst Optimism 23 January 2026
Wetherspoon (JDW.L) Investor Outlook: Navigating Growth in the UK Restaurant Industry 23 January 2026
